[HTML][HTML] Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus
F Olayinka-Adefemi, S Hou, AJ Marshall - Frontiers in Immunology, 2023 - frontiersin.org
Phosphoinositide 3-kinase delta (PI3Kδ) plays key roles in normal B cell activation and is
chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved drugs …
chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved drugs …
[HTML][HTML] Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus
F Olayinka-Adefemi, S Hou, AJ Marshall - Frontiers in Immunology, 2023 - ncbi.nlm.nih.gov
Abstract Phosphoinositide 3-kinase delta (PI3Kδ) plays key roles in normal B cell activation
and is chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved …
and is chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved …
Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus
F Olayinka-Adefemi, S Hou… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Phosphoinositide 3-kinase delta (PI3Kδ) plays key roles in normal B cell activation and is
chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved drugs …
chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved drugs …
Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus.
F Olayinka-Adefemi, S Hou, AJ Marshall - Frontiers in Immunology, 2023 - europepmc.org
Phosphoinositide 3-kinase delta (PI3Kδ) plays key roles in normal B cell activation and is
chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved drugs …
chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved drugs …
Folayemi Olayinka-Adefemi, Sen Hou and Aaron J. Marshall
LA Smyth, L Liangjing, A Satterthwaite, AJ Marshall - 2023 - europepmc.org
Abstract Phosphoinositide 3-kinase delta (PI3Kδ) plays key roles in normal B cell activation
and is chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved …
and is chronically activated in malignant B cells. Targeting of PI3Kδ using FDA-approved …